Is Livzon Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Livzon Pharmaceutical pays dividends. Last time was Monday 5th of August 2024 where the investors holding the stock on Monday 8th of July 2024 were paid HKD1.48203 per share. Over the last 11 times between 2014 and 2024, Livzon Pharmaceutical has paid HKD12.92596 with an average of HKD1.18 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Livzon Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD22.20, you would have made a profit of HKD3.20 per share or 14.41%
Yes, the average daily trading liquidity for Livzon Pharmaceutical is HKD494 365 thousand. You should therefore be able to get in and out of your positions relatively fast.
Livzon Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.09, the company's ability to pay off the debt is good. Livzon Pharmaceutical has a good net profit margin of 16.15% and should have high tolerances against inflation.
We have calculated the inflation risk for Livzon Pharmaceutical to be low [0.25 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.